JESSE PRICE: Open Payments
NPI 1093091761 · MT PLEASANT, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,145 in 61 payments from 16 companies in 2025. Trend: 2023 $527 · 2024 $1,382 · 2025 $1,145
Food & beverage: $1,145
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 15 | $291 |
| Amgen Inc. | 9 | $142 |
| Novo Nordisk Inc | 6 | $124 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $91 |
| ABBVIE INC. | 5 | $84 |
| Sumitomo Pharma America, Inc. | 3 | $78 |
| Novartis Pharmaceuticals Corporation | 3 | $59 |
| SHIELD THERAPEUTICS INC | 3 | $49 |
| Exact Sciences Corporation | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
Products named: ELIQUIS, PREVNAR 20, REPATHA, NURTEC ODT, XIFAXAN, GEMTESA, Wegovy, ACCRUFER.
Industry payments across SC — which companies pay providers there.
